Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) General Information

Description

A clinical phase 3-ready oral beta-lactam/beta-lactamase inhibitor (BL/BLI) combination antibiotic drug. The drug is the combination of ceftibuten, an orally bioavailable cephalosporin antibiotic, and ledaborbactam etzadroxil, the orally bioavailable prodrug of the novel beta-lactamase inhibitor ledaborbactam used for the potential treatment of complicated urinary tract infections (cUTI), including pyelonephritis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Malvern, PA
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Buildings and Property
Drug Discovery
Acquirer
Basilea Pharmaceutica
Corporate Office
  • Malvern, PA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug)‘s full profile, request access.

Request a free trial

Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug)‘s full profile, request access.

Request a free trial

Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) FAQs

  • Where is Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) headquartered?

    Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) is headquartered in Malvern, PA.

  • What industry is Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) in?

    Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug)’s primary industry is Pharmaceuticals.

  • Is Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) a private or public company?

    Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) is a Private company.

  • What is the current valuation of Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug)?

    The current valuation of Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) is .

  • What is Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug)’s current revenue?

    The current revenue for Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) is .

  • Who are Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug)’s investors?

    Venatorx Pharmaceuticals has invested in Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug).

  • When was Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) acquired?

    Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) was acquired on 14-Aug-2025.

  • Who acquired Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug)?

    Venatorx (Ceftibuten-Ledaborbactam Etzadroxil Antibiotic Drug) was acquired by Basilea Pharmaceutica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process